AURO LABORATORIES
Back to Cashflow Statement
|
AURO LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹14 Cr | ₹18 Cr | ₹19 Cr | ₹-8.18 Cr | ₹9.79 Cr |
What is the latest Cash Flow from Financing Activities ratio of AURO LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹14 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹-8.18 Cr |
| Mar2022 | ₹9.79 Cr |
How is Cash Flow from Financing Activities of AURO LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | -20.64 | |
| Mar2025 | ₹18 Cr | -7.37 | |
| Mar2024 | ₹19 Cr | Positive | |
| Mar2023 | ₹-8.18 Cr | Negative | |
| Mar2022 | ₹9.79 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AURO LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AURO LABORATORIES | ₹148.7 Cr | 2.1% | -4.8% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
AURO LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AURO LABORATORIES | 2.1% |
-4.8% |
-12.7% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses